Are Nutraceuticals Effective in COVID‐19 and Post‐COVID Prevention and Treatment?

The beginning of the end or the end of the beginning? After two years mastered by coronavirus disease 19 (COVID‐19) pandemic, we are now witnessing a turnaround. The reduction of severe cases and deaths from COVID‐19 led to increasing importance of a new disease called post‐COVID syndrome. The term post‐COVID is used to indicate permanency of symptoms in patients who have recovered from severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Immune, antiviral, antimicrobial therapies, as well as ozone therapy have been used to treat COVID‐19 disease. Vaccines have then become available and administered worldwide to prevent the insurgence of the disease. However, the pandemic is not over yet at all given the emergence of new omicron variants. New therapeutic strategies are urgently needed. In this view, great interest was found in nutraceutical products, including vitamins (C, D, and E), minerals (zinc), melatonin, probiotics, flavonoids (quercetin), and curcumin. This review summarizes the role of nutraceuticals in the prevention and/or treatment of COVID‐19 disease and post‐COVID syndrome.